Medscape

NICE Gives Green Light to Teduglutide for Short Bowel Syndrome

The National Institute for Health and Care Excellence (NICE) has recommended the use of teduglutide for the treatment of people with short bowel syndrome (SBS). In a draft guidance published on June 1 ...
EurekAlert!

Reprogramming gut cells to treat short bowel syndrome

SATB2 deficiency confers small intestinal (ileal) properties on colon cells. Green fluorescent marker bound to cholesterol (top row) and glucose (bottom row) shows absorption of nutrients in: a) Ileal ...
Medscape

The Medical and Surgical Management of Short Bowel Syndrome

In the absence of registry data, it is impossible to know the precise incidence and prevalence of short bowel syndrome in the United States. On the basis of European data, the incidence of total ...
Business Wire

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and ...

Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi

Jaguar has received the initial $16M payment related to the company's recently executed US out-license agreement for Mytesi ® ...
equities

Zealand Pharma Enrolls First Patient in Phase 3 Trial for Short Bowel Syndrome

Short bowel syndrome is a complex group of diseases caused by the loss (or loss of function) of part of the small and/or large intestine. Patients with short bowel syndrome can’t absorb sufficient ...
Nature

Short Bowel Syndrome and Parenteral Nutrition

Short Bowel Syndrome (SBS) is a multifaceted condition arising from extensive surgical resection of the small intestine, which leads to impaired nutrient absorption and a heightened risk of ...
clinicaladvisor.com

Apraglutide Gets Orphan Drug Designation for Short Bowel Syndrome

FDA orphan drug granted. The Company has already completed a Phase 1 trial of this synthetic glucagon-like peptide (GLP-2) analog. The Food and Drug Administration (FDA) has granted Orphan Drug ...
Healio

Teduglutide improves stool outcomes in children with short bowel syndrome over 96 weeks

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Stool frequency and consistency improved over 96 weeks ...
Healio

AGA offers 12 best practice recommendations for managing short bowel syndrome

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The AGA has released a clinical practice update and ...
Becker's Hospital Review

Short Bowel Syndrome Drug Receives FDA Drug Advisory Committee Recommendation

Gattex (teduglutide), a drug for the treatment of adult short bowel syndrome, has received a recommendation for approval from the FDA’s Gastrointestinal Drugs Advisory Committee, according to a news ...
KTLA

Short Bowel Syndrome: Loss of Venous Access Via PICC Lines Versus Small Bowel Transplant

Adults and children with Short Bowel Syndrome are at serious risk of central line associate blood-stream infections and recurrent loss of venous access. Without progressive loss of venous access, at ...